FREMONT, Calif.--(BUSINESS WIRE)--AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the successful initiation of enrollment in the AngioSculpt® Scoring Balloon Catheter Multi-Center Coronary Bifurcation Study, or AGILITY trial.
